Showing results (21-30 of 269) with videos related to

Sort By:
Pageof 27
The Oncologist|August 25, 2019
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive ValueFederica Miglietta, Gaia Griguolo, Valentina Guarneri, et al.
Cancer Treatment Reviews|May 23, 2021
Neoadjuvant approach as a platform for treatment personalization: focus on HER2-positive and triple-negative breast cancerFederica Miglietta, Maria Vittoria Dieci, Gaia Griguolo, et al.
Cancer Letters|August 22, 2006
Primary systemic therapy for operable breast cancer: a review of clinical trials and perspectivesValentina Guarneri, Antonio Frassoldati, Simona Giovannelli, et al.
Critical Reviews in Oncology/Hematology|July 1, 2018
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?Stefano Frega, Laura Bonanno, Valentina Guarneri, et al.
The Oncologist|June 28, 2014
Rare breast cancer subtypes: histological, molecular, and clinical peculiaritiesMaria Vittoria Dieci, Enrico Orvieto, Massimo Dominici, et al.
Expert Review of Anticancer Therapy|December 21, 2010
Timing for starting second-line therapy in recurrent ovarian cancerValentina Guarneri, Elena Barbieri, Maria Vittoria Dieci, et al.
Future Oncology (London, England)|April 7, 2020
Olaparib for advanced breast cancerGaia Griguolo, Maria Vittoria Dieci, Federica Miglietta, et al.
Clinical Breast Cancer|November 10, 2005
Predictive value of biologic parameters for primary chemotherapy in operable breast cancerAntonio Frassoldati, Michela Maur, Valentina Guarneri, et al.
Journal for Immunotherapy of Cancer|March 30, 2019
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancerGaia Griguolo, Tomás Pascual, Maria Vittoria Dieci, et al.
Pageof 27